logo-loader

Celgene Corporation

Receive alerts
Market:
NASDAQ
Market Cap:
$77.04 billion
Price
108.24 USD
Change
0.10%
52 weeks high
110.70
52 weeks low
58.61

In brief

Celgene Corporation is an integrated biopharmaceutical company primarily engaged in the discovery, development and commercialization of therapies designed to treat cancer and immune-inflammatory related diseases.